Tapering and Discontinuing Paroxetine 10 mg

Introduction to Paroxetine Tapering

Paroxetine should be tapered gradually over several weeks to months, reducing the dose by the smallest increment possible in successive steps of at least several days' duration to minimize withdrawal symptoms, as recommended by the American Academy of Sleep Medicine and the American Academy of Child and Adolescent Psychiatry 1, 2

Paroxetine is associated with a significant discontinuation syndrome, particularly when stopped abruptly, which can include dizziness, fatigue, lethargy, general malaise, myalgias, chills, headaches, according to the American Academy of Child and Adolescent Psychiatry 2
The discontinuation syndrome can also include nausea, vomiting, diarrhea, insomnia, as reported by the American Academy of Child and Adolescent Psychiatry 2
Imbalance, vertigo, sensory disturbances, paresthesias are also symptoms of the discontinuation syndrome, as noted by the American Academy of Child and Adolescent Psychiatry 2
Anxiety, irritability, and agitation can occur as part of the discontinuation syndrome, as stated by the American Academy of Child and Adolescent Psychiatry 2
Abnormal dreams are a symptom of the discontinuation syndrome, according to the American Academy of Sleep Medicine 1

The American Academy of Sleep Medicine recommends discussing the tapering plan with a healthcare provider before starting and considering timing to avoid stressful life periods for discontinuation 1
The American Academy of Sleep Medicine suggests considering cognitive-behavioral therapy during tapering to increase success rates 1
The Mayo Clinic recommends discussing the tapering plan with a healthcare provider before starting 3

The American Academy of Sleep Medicine recommends reducing the dose by the smallest increment possible (e.g., 2.5 mg) at each step 1
The American Academy of Child and Adolescent Psychiatry suggests allowing at least several days (preferably 1-2 weeks) between each dose reduction 2
A sample schedule might be:
- 7.5 mg daily for 1-2 weeks, as recommended by the Mayo Clinic 3
- 5 mg daily for 1-2 weeks, as recommended by the Mayo Clinic 3
- 2.5 mg daily for 1-2 weeks, as recommended by the Mayo Clinic 3

The American Academy of Sleep Medicine recommends considering tapering frequency instead of dose if symptoms emerge during dose reduction 1
The American Academy of Sleep Medicine suggests taking the medication every other day or every third day before complete cessation 1

The American Academy of Sleep Medicine notes that successful tapering may require several weeks to months, especially for patients who have been on paroxetine long-term 1
The American Academy of Child and Adolescent Psychiatry recommends that paroxetine has a relatively short half-life compared to other SSRIs, making it more likely to cause withdrawal symptoms when discontinued 2

The American Academy of Sleep Medicine recommends monitoring for withdrawal symptoms, which typically appear within 1-3 days of dose reduction 1

The Mayo Clinic Proceedings recommends tapering paroxetine gradually to minimize discontinuation syndrome, with a taper considered successful as long as the patient is making progress 4
The Mayo Clinic Proceedings advises against abrupt discontinuation of paroxetine, except in extreme cases, and suggests that sudden cessation is no more appropriate with paroxetine than with antihypertensives or antihyperglycemics 4

The Mayo Clinic Proceedings warns against mistaking withdrawal symptoms for relapse, and notes that discontinuation syndrome can be misdiagnosed as depression recurrence, leading to unnecessary long-term medication continuation 4
The Mayo Clinic Proceedings emphasizes the importance of avoiding "cold referrals" to clinicians who have not agreed to accept the patient, and notes that the prescribing clinician is obligated to either offer a comfortable tapering regimen or obtain agreement from another physician to provide care 4
The Mayo Clinic Proceedings recommends that the taper may need to be paused and restarted when the patient is ready, and should be slowed once reaching low dosages 4